Business
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
MISSISSAUGA, Ontario, February 19, 2026--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced an upcoming Continuing Education webinar to be presented by internationally recognized vascular access expert Dr. Nancy Moureau and hosted by the distinguished Association for Vascular Access (AVA), a leading global authority on vascular access.
About this update from Covalon Technologies Ltd.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":261,"url":"https://media.zenfs.com/en/business-wire.com/86c4858b556af25a2e12214450a20717"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8Fm79AOTL2Om_sNPTz53Kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUyMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/86c4858b556af25a2e12214450a20717","width":480,"height":261}},"lazy":false},{"type":"text","content":"MISSISSAUGA, Ontario, February 19, 2026--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced an upcoming Continuing Education webinar to be presented by internationally recognized vascular access expert Dr. Nancy Moureau and hosted by the distinguished Association for Vascular Access (AVA), a leading global authority on vascular access.","length":521,"tagName":"p"},{"type":"text","content":"The webinar will focus on the persistent clinical challenge of IV line contamination and its contribution to Catheter-Associated Blood Stream Infection (CABSI) risk - an important patient safety issue across care settings.","length":222,"tagName":"p"},{"type":"text","content":""Life-threatening complications stemming from IV line contamination are not inevitable, they are preventable," said Dr. Nancy Moureau, PhD, RN, CRNI, CPUI, VA-BC. "When we address contamination at its source, we directly strengthen patient safety. This session challenges clinicians to examine and refine the everyday practices that protect our patients from serious harm, improve outcomes, and creates consistent, evidence-based care that meaningfully reduces infection risk."","length":497,"tagName":"p"},{"type":"text","content":""IV lines are a literal lifeline for millions of patients each year, and simple, easy-to-implement improvements in everyday practice can have a significant positive impact on patient outcomes," said Dr. Katherine Evely, PhD, Vice President of Clinical Affairs for Covalon. "We are proud to support clinician education in close collaboration with AVA and Dr. Moureau. Our goal is to advance practical approaches that strengthen vascular acces...